• Mon espace de travail
  • Aide IRIS
  • Par Publication Par Personne Par Unité
    • English
    • Français
  • Se connecter
Logo du site

IRIS | Système d’Information de la Recherche Institutionnelle

  • Accueil
  • Personnes
  • Publications
  • Unités
  • Périodiques
UNIL
  • English
  • Français
Se connecter
IRIS
  • Accueil
  • Personnes
  • Publications
  • Unités
  • Périodiques
  • Mon espace de travail
  • Aide IRIS

Parcourir IRIS

  • Par Publication
  • Par Personne
  • Par Unité
  1. Accueil
  2. IRIS
  3. Publication
  4. Evaluation of serum myostatin and sclerostin levels in chronic spinal cord injured patients.
 
  • Détails
Titre

Evaluation of serum myostatin and sclerostin levels in chronic spinal cord injured patients.

Type
article
Institution
UNIL/CHUV/Unisanté + institutions partenaires
Périodique
Spinal Cord  
Auteur(s)
Invernizzi, M.
Auteure/Auteur
Carda, S.
Auteure/Auteur
Rizzi, M.
Auteure/Auteur
Grana, E.
Auteure/Auteur
Squarzanti, D.F.
Auteure/Auteur
Cisari, C.
Auteure/Auteur
Molinari, C.
Auteure/Auteur
Renò, F.
Auteure/Auteur
Liens vers les personnes
Carda, Stefano  
Liens vers les unités
Neuropsycho. et neuroréhabilitation  
ISSN
1476-5624
Statut éditorial
Publié
Date de publication
2015
Volume
53
Numéro
8
Première page
615
Dernière page/numéro d’article
620
Peer-reviewed
Oui
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: ppublish
Résumé
STUDY DESIGN: Case-control study.
OBJECTIVES: To assess serum myostatin levels, bone mineral density (BMD), appendicular skeletal muscle mass (ASMM) and serum sclerostin levels in chronic spinal cord injured (SCI) patients and healthy controls.
SETTING: SCI centre in Italy.
METHODS: Blood samples, whole-body bioelectrical impedance analysis and BMD measurement with the ultrasound technique at the calcaneus level were taken from patients suffering from chronic SCI (both motor complete and incomplete) and healthy control subjects.
RESULTS: A total of 28 SCI patients and 15 healthy controls were enrolled. Serum myostatin levels were statistically higher (P<0.01) in SCI patients compared with healthy controls. Similar results were found comparing both the motor complete and the motor incomplete SCI subgroups to healthy controls. Serum sclerostin was significantly higher in patients with SCI compared with healthy controls (P<0.01). BMD, stiffness and mean T-score values in SCI patients were significantly lower than those in healthy controls. Serum myostatin concentrations in the motor complete SCI subgroups correlated only with serum sclerostin levels (r(2)=0.42; P=0.001) and ASMM (r(2)=0.70; P=0.002) but not in healthy controls.
DISCUSSION: Serum myostatin and serum sclerostin are significantly higher in chronic SCI patients compared with healthy controls. They are potential biomarkers of muscle and bone modifications after SCI. This is the first study reporting an increase in serum myostatin in patients suffering from chronic SCI and a correlation with ASMM.
Sujets

Adolescent

Adult

Blood Chemical Analys...

Bone Morphogenetic Pr...

Chronic Disease

Enzyme-Linked Immunos...

Female

Genetic Markers

Humans

Male

Middle Aged

Movement Disorders/et...

Myostatin/blood

Severity of Illness I...

Spinal Cord Injuries/...

Spinal Cord Injuries/...

Statistics as Topic

Statistics, Nonparame...

Young Adult

PID Serval
serval:BIB_474831B6CFDD
DOI
10.1038/sc.2015.61
PMID
25896346
WOS
000359325900009
Permalien
https://iris.unil.ch/handle/iris/98196
Open Access
Oui
Date de création
2015-08-28T16:32:30.601Z
Date de création dans IRIS
2025-05-20T18:24:19Z
Fichier(s)
En cours de chargement...
Vignette d'image
Nom

sc201561.pdf

Version du manuscrit

published

Taille

362.89 KB

Format

Adobe PDF

PID Serval

serval:BIB_474831B6CFDD.P001

Somme de contrôle

(MD5):4ed604b83994891d81fec851b17d05f1

  • Copyright © 2024 UNIL
  • Informations légales